NEW YORK, NY / ACCESSWIRE / February 24, 2020 / Reliance Worldwide Corp. Ltd. (ASX:RWC) will be discussing their earnings results in their 2020 First Half Earnings call to be held on February 24, 2020 at 9:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/58706

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what's trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 577416

EDMONTON, ALBERTA, CANADA / ACCESSWIRE / February 24, 2020 / OneSoft Solutions Inc. (the "Company" or "OneSoft") (TSX-V:OSS) (OTCQB:OSSIF) is pleased to announce that representatives from the Company's wholly owned operating subsidiary, OneBridge Solutions Inc. ("OneBridge"), presented a white paper profiling Statistical Analysis of Dig Operations (the "Study") to pipeline industry professionals at PPIM 2020, the industry's primary forum devoted exclusively to pigging for maintenance and inspection, as well as pipeline integrity evaluation and repair. The white paper confirms the high value proposition of utilizing OneBridge's technology and products.

The Study was compiled by OneBridge employees Dr. Yevgeniy Petrov, Jordan Dubuc, Michael H. Murray and Tim Edward and based on statistical analysis performed by OneBridge's Cognitive Integrity Management ("CIM") solution. Data used for the study involved 1,074 in-line inspection ("ILI") runs conducted between 1991 and 2017, on pipelines with installation dates ranging from 1920 to 2016 and more than 23,000 digs that were performed between 1959 and 2019, resulting in 171 miles of pipeline excavations in aggregate.

Based on historic dig records, we determined whether a productive (i.e., a necessary dig) repair was performed or if the pipe was simply recoated without additional action taken (an un-necessary dig) to calculate the "Repair Fraction", as an assessment of the overall effectiveness of a dig program. With some variations, the Repair Fraction for the data used in this study was mostly consistent between 40 to 60% of digs completed.

The capability of CIM to assess pit-to-pit anomaly growth over multiple ILI runs enables pipeline operators to measure effects of specific factors to improve the Repair Fraction through identification of opportunities to optimize dig selection criteria to improve integrity management decision-making. For example, anomalies with higher growth rates should merit a repair more often than those with low growth rates. Whereas the CIM pit-to-pit growth model does exhibit this trend, the "half-life"-based model that is used by certain operators today shows a flat or negative correlation between Repair Fraction and anomaly growth, indicating that the half-life model does not as accurately identify anomalies that are most risky or in need of repair.

The Study concludes that OneBridge's new tools and methodologies made available through advances in data science and machine learning allow clients to improve their integrity management programs. With CIM's structured approach to integrity management decision-making, more rigorous management and analysis of integrity data and the use of modern tools which leverage the computational power of the cloud provide significant opportunity for deeper analysis and inspection of integrity management programs. The types of analysis presented can guide operators toward a more effective integrity program and allocation of dig program funds, and also potentially reduce overall risk by improving the selection of prioritized digs.

"This is our first such quantifiable study that has been published and we are in process of developing additional models where the learnings will be shared across our customers from both a risk and financial perspective. This would not be possible without having first built our CIM platform to aggregate big data from our customers and prospects, which involves tens of thousands of miles of pipeline data and learnings from more than 50 million features," said Tim Edward, OneBridge President. "Even a 1% delta in improving Repair Fraction is significant, and we believe our customers may see efficiency gains in the 10 or 20% range, which will greatly improve their risk and financial metrics through use of CIM."

"This was our fourth attendance at PPIM, which has been an annual occurrence since we founded OneBridge," said Brandon Taylor, President and COO of OneSoft. "We met numerous clients, prospective clients and partners during the week who have been monitoring our progress and considering adoption of our CIM platform. New technology alternatives are typically showcased at PPIM and we remain confident that we are leading in innovation for the industry and can continue to scale revenue and growth based on the solid product and business strategies that we have developed to date."

The full Study report and video of the OneBridge PPIM presentation can be accessed by clicking on the links provided.

About PPIM

The white paper was presented as part of the Pipeline Pigging and Integrity Management ("PPIM") conference program held in Houston, Texas February 17-21, 2020, the oil and gas pipeline industry's primary forum devoted exclusively to pigging for maintenance and inspection, as well as integrity evaluation and repair. Established in 1989, PPIM is celebrated its 32nd anniversary in 2020, with a global attendee presence. For more information, visit www.clarion.org/ppim/ppim20/index.php.

About OneSoft and OneBridge

OneSoft has developed software technology and products that have capability to transition legacy, on-premise licensed software applications to operate on the Microsoft [NASDAQ:MSFT] Azure Cloud Platform. Our business strategy is to seek opportunities to incorporate Data Science and Machine Learning, business intelligence and predictive analytics to create cost-efficient, subscription-based software-as-a-service solutions. Visit www.onesoft.ca for more information.

OneSoft's wholly owned subsidiary, OneBridge Solutions Inc., develops and markets revolutionary new SaaS solutions that use advanced Data Sciences and Machine Learning to analyze big data using predictive analytics to assist Oil & Gas pipeline operators to predict pipeline failures and thereby save lives, protect the environment, reduce operational costs and address regulatory compliance requirements. Visit www.onebridgesolutions.com for more information.

For more information, please contact

Dwayne Kushniruk, CEO
dkushniruk@onesoft.ca
(780) 437‐4950

Sean Peasgood, Investor Relations
Sean@SophicCapital.com
(647) 494-7710

Forward-looking Statements

This news release contains forward-looking statements relating to the future operations, product creation revenues and profitability of the Company, the Company's efforts to develop and commercialize the technology with the capabilities and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expects", "believe", "will", "intends", "plans" and similar expressions. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Such forward-looking information is provided for the purpose of delivering information about management's current expectations and plans relating to the future. Investors are cautioned that reliance on such information may not be appropriate for other purposes, such as making investment decisions.

In respect of the forward-looking information and statements, the Company has placed reliance on certain assumptions that it believes are reasonable at this time, including expectations and assumptions concerning, among other things: interest and foreign exchange rates; planned synergies, capital efficiencies and cost-savings; applicable tax laws; the sufficiency of budgeted capital expenditures in carrying out planned activities; the availability and cost of labour and services; the efficacy of its software, its ability to complete projects to expected deadlines, the success of growth projects; future operating costs; that counterparties to material agreements will continue to perform in a timely manner; that there are no unforeseen events preventing the performance of contracts; and that there are no unforeseen material development or other costs related to current growth projects or current operations. Accordingly, readers should not place undue reliance on the forward-looking information contained in this press release. Since forward-looking information addresses future events and conditions, such information by its very nature involves inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to many factors and risks. These include, but are not limited to the risks associated with the industries in which the Company operates in general such as: costs and expenses; interest rate and exchange rate fluctuations; competition; human capital engagement and availability, ability to access sufficient financial capital from internal and external sources; and changes in legislation, including but not limited to tax laws.

Readers are cautioned that the foregoing list of factors is not exhaustive. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by Canadian securities law.

This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities within the United States. The securities to be offered have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of such Act or other laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: OneSoft Solutions Inc.

ReleaseID: 577483

VANCOUVER, BC / ACCESSWIRE / February 24, 2020 / Gold Terra Resources Corp (TSX-V: YGT; Frankfurt: TX0; OTC Pink: TRXXF) is pleased to announce the results of 3 holes from the winter 2020 drill campaign at Sam Otto South. (Figure 1) This drilling is designed to expand mineralized zones identified in the November 2019 NI 43-101 mineral resource report. Highlights include 25 meters of 1.39 g/t gold (including 10.59 meters of 2.48 g/t gold) in hole TSO20-058. In addition, Hole TSO20-53 intersected the main zone with a higher-grade intersection of 2.0 meters of 6.24 g/t gold.

Message from David Suda, President and CEO:

"There is early excitement within our technical team around the first batch of assays from Sam Otto. The identification of a new mineralized structure at Sam Otto South underlines the potential to add ounces to the current inferred resource (see attached level plan 40m asl or -150m below surface). We feel that we are at the beginning of a significant expansion of the Sam Otto Zone with these first results with 5 out of 6 remaining holes showing visible gold still pending assays."

Gold Terra has drilled a further 14 holes, including 3 holes in the Connector Zone between Sam Otto Main and Sam Otto South, and 2 holes that extend the strike of the Sam Otto Main Zone south. Assay results for these holes are pending. The company is approximately halfway through the winter 2020 drilling program. (Figure 1)

Technical Summary:

Drill hole TS020-058 is situated 50 meters to the north of drill hole TS018-035 that intersected 27.16 meters of 2.16 g/t gold (News Release reported March 9, 2018) and has intersected a new hangingwall mineralized structure within the Sam Otto South zone that is within 50 meters of the previously identified mineralized structure that formed the basis of Gold Terra's exploration program at Sam Otto South (Figure 2). Only the top half of the hole has been reported but the lower half has encountered visible gold within the principle zone at Sam Otto South and screen metallic assaying is pending.

Drill holes TS020-052 and TS020-053 were drilled 100 meters north and 50 meters below drill hole TS018-035 respectively. TS020-052 intersected multiple mineralized structures with best results in the new hanging wall zone of 5.0 meters of 1.56 g/t Au and 3.3 meters of 1.05 g/t au. TS020-053 intersected 39.69 meters of 0.53 g/t gold in the main zone, including 2.0 meters of 6.24 g/t gold.

Gold mineralization encountered within the Sam Otto South target is in shear zone structures 100 – 200 meters in width with strong sericite alteration and shearing. Gold mineralized zones are directly associated with modest (1-2%) sulphide content in sheared and altered intermediate volcanic rocks. These geological characteristics are consistent with what is observed at the Sam Otto Main zone 1.5 kilometers to the north.

Technical Appendix:

Holes were drilled normal to strike length and designed to cross mineralized structures at right-angles. Reported intersection widths are estimated to be 83-90% of true width.

For the 3 holes reported today, Gold Terra collected 656 samples for assay. Results ranged from below detection to 7.14 g/t Au. Gold Terra inserts certified standards and blanks into the sample stream as a check on laboratory QC. Drill core samples are cut by diamond saw at Gold Terra's core facilities in Yellowknife. A halved core sample is left in the core box. The other half core is sampled and transported by Gold Terra personnel in securely sealed bags to ALS Chemex's (ALS) preparation laboratory in Yellowknife. After sample preparation, samples are shipped to ALS's Vancouver facility for gold analysis. Gold assays of >3 g/t are re-assayed on a 30 g split by fire assay with a gravimetric finish. For one sample (7.14 g/t Au with visible gold) ALS required a third fire assay. ALS is a certified and accredited laboratory service. ALS routinely inserts certified gold standards, blanks and pulp duplicates, and results of all QC samples are reported.

The technical information contained in this news release has been approved by Joseph Campbell who is a Qualified Person as defined in "National Instrument 43-101, Standards of Disclosure for Mineral Projects.

About Gold Terra Resource Corp

Gold Terra owns a 100% interest in the YCG Project, encompassing 790 sq km of contiguous land within 10 kilometers of the city of Yellowknife. The Company announced an inferred mineral resource estimate of 735,000 ounces of gold in November 2019, (News release November 4th 2019). The YCG Project is located in the same archean belt where the former high-grade Con and Giant gold mines have produced over 14 million ounces of gold. The YCG project is located north and south of the city and along the same mineralized district scale as the past producer Con and Giant Mines.

For more information on the YCG project, please visit our website at www.goldterracorp.com.

On behalf of the Board of Directors,

"DAVID SUDA"

David Suda
President and CEO

For more information, please contact:
Samuel Vella
Manager of Corporate Communications
Phone: 604-689-1749 / Toll-Free: 1-855-737-2684
svella@goldterracorp.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Information

Certain statements made and information contained in this news release constitute "forward-looking information" within the meaning of applicable securities legislation ( "forward-looking information"). Generally, this forward-looking information can, but not always, be identified by use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events, conditions or results "will", "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotations thereof.

All statements other than statements of historical fact may be forward-looking information. Forward-looking information is necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. In particular, this news release contains forward-looking information regarding the anticipated timing for the commencement of trading under the Company's new name and trading symbol and the anticipated development of the Company's YCG Project. There can be no assurance that such statements will prove to be accurate, as the Company's actual results and future events could differ materially from those anticipated in this forward-looking information as a result of the factors discussed in the "Risk Factors" section in the Company's most recent MD&A and annual information form available under the Company's profile at www.sedar.com.

Although the Company has attempted to identify important factors that would cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. The forward-looking information contained in this news release is based on information available to the Company as of the date of this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. All of the forward-looking information contained in this news release is qualified by these cautionary statements. Readers are cautioned not to place undue reliance on forward-looking information due to the inherent uncertainty thereof. Except as required under applicable securities legislation and regulations applicable to the Company, the Company does not intend, and does not assume any obligation, to update this forward-looking information.

SOURCE: Gold Terra Resources Corp

ReleaseID: 577524

VANCOUVER , BC / ACCESSWIRE / February 24, 2020 / International Mining Corp (CSE: IMCX) (OTC: IMIMF) (the "Company" or "IMC"), is pleased to announce it has completed a non-brokered private placement (the "Offering") of 3,110,000 units (each, a "Unit"), at a price of $0.25 CDN per Unit, for aggregate gross proceeds of $777,500 CDN. Each Unit consists of one common share in the capital of the Company (each, a "Common Share", and collectively, the "Common Shares"), and one common share purchase warrant (a "Warrant"). Each Warrant is exercisable to acquire one additional common share of the Company for two years at a price of $0.40 CDN per share.

All securities issued in connection with the private placement are subject to final approval of the Canadian Securities Exchange (the "CSE") and the statutory four-hold period expiring June 22, 2020.

The proceeds of the financing will be used principally for the exploration of the Company's Bullard Pass Property in Arizona, USA, the Thane Property in British Columbia, Canada, and for general working capital purposes.

The Company paid finders' fees of $21,750 CDN in cash and issued 87,000 finder warrants, with each finder warrant entitling the holder thereof to acquire a Common Share at a price of $0.40 CDN per Common Share until February 21, 2022.

In addition, the Company announces the appointment of David Charlton as the Company's new Chief Financial Officer. Mr. Charlton is a Chartered Professional Accountant (CPA) with over 7 years' experience working with junior mining, oil and gas, blockchain and cryptocurrency companies in the public sector. Prior to joining the Company, David worked for midsize audit firms where he serviced a variety of TSX Venture Exchange and CSE-listed companies in audit and assurance, business consultation, financial statement preparation and compliance.

The Company wishes to thank outgoing Chief Financial Officer, Eli Dusenbury, for his service over the past year.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States of America absent registration or an applicable exemption from registration requirements.

ON BEHALF OF THE BOARD OF DIRECTORS

Brian Thurston

Chief Executive Officer and President

ABOUT INTERNATIONAL MINING CORP.

IMC International Mining Corp. is a junior exploration and development company. It is focused on creating shareholder value through the acquisition, exploration and development of gold assets, which include the Company's 100% owned Bullard Pass Property in Arizona.

IMC continues to evaluate additional properties to add to its portfolio of mining assets.

INVESTOR RELATIONS:
ir@internationalmining.ca
1 (604) 588-2110
https://imcxmining.com

Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable securities laws, including statements regarding: the completion of the Private Placement, the Company's intention to acquire further mineral properties; the Company's business plans and prospects and the future of the Company's business, the acquisition, exploration and development of its assets; and the ability to create shareholder value. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Private Placement may not complete in the full amount contemplated, or at all, that the Company may not acquire any additional mineral properties, that the Company's plans and prospects will vary from those stated in this news release and that the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Accordingly, readers should not place undue reliance on forward-looking information. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release.

SOURCE: IMC International Mining Corp.

ReleaseID: 577508

Sustainable Agriculture Meets Renewable Energy

BROOMFIELD, CO / ACCEESSWIRE / February 24, 2020 / Strategic Environmental & Energy Resources Inc.'s (SEER) (OTCQB: SENR), a provider of environmental, renewable fuel and industrial waste stream management services, has been awarded a $660,000 contract to install one of its proprietary gas conditioning systems at one of the largest food processors in the NW United States. The H2SPlus™ system will remove the H2S from the biogas generated from a covered lagoon at one of the nation's largest potato processing plants. The customer's decision to contract with MV Technologies ("MV") was based on the positive results at a similar processing plant where MV previously installed a large H2SPlus™ system that has continued to perform efficiently and reliably since its installation years ago.

The H2SPlus™ system is designed to treat a peak flow rate of 800 SCFM with a concentration range of 2,500 to 5,000 ppm of H2S. The project will generate approximately $250,000 in recurring annual media sales of SEER's in-house BioActive Media™ ("BAM"™) for the life of the system which is expected to be more than 10 years.

"I am excited to start the year off with the sale of a large system that will continue to generate ongoing revenue for many years to come," said Tom Jones, President of MV. In addition, Mr. Jones stated, "I am encouraged by all the recent inquiries from developers of biogas projects at landfills and anaerobic digesters that are developing RNG projects at their facilities. It is encouraging that developers continue to take advantage of the RINs and LCFS monetary incentives."

In addition to the larger fixed-site systems, MV continues to increase placements of its modular gas conditioning systems through rentals and sales. MV has the ability to place the modular units into service quickly to assist its customers with specific compliance requirements for their air emission permits. MV recently received a contract to install a rental unit at a dairy in Idaho. This will generate approximately $30,000 in annual rental revenue and an additional $125,000 in revenue annually from the sales of MV's iron oxide granular media. "Total recurring media sales utilized in MV H2S treatment systems for 2019 was approximately $3M. Approximately one-third of this total is direct sales of our SEM/iron sponge media on which MV realizes income and the balance is the sale of our licensed granular iron oxide media on which MV receives a commission. As system sales continue, these recurring media sales will continue to grow." said Jones.

With sustainability being in the forefront of many industry objectives, MV remains committed to helping its customers: 1) remove H2S and achieve SOx compliance limits, 2) extend the operating life of downstream gas-to-energy equipment, 3) reduce maintenance costs, 4) comply with stringent pipeline/CNG/RNG specifications where the biogas is used as a fuel source, 5) protect flares and thermal oxidizers from corrosion, and 6) meet equipment warranty requirements. This commitment is evidenced by MV's many years of partnering and working closely with large food processors, many of which have installed several systems at different facilities. "Use of MV's H2SPlus™ systems, integrated with SEER's biologically enhanced media can help generators of biogas and LFG honor their commitment to sustainability and simultaneously achieve continued profitability," said Mr. John Combs III, SEER's CEO. "Merging environmental compliance and stewardship with corporate objectives and profitability is at the core of SEER's mission. Our customers are also dedicated to sustainability, and they seek committed long-term partners that share these values. This most recent sale and deployment of our MV system demonstrates our ongoing success in providing cost-effective and reliable solutions to H2S control across a wide variety of applications," said Combs.

About MV Technologies

MV Technologies is an industry leader specializing in air emissions and odor control solutions with an emphasis on dry scrubber H2S removal systems for a broad range of industrial applications. MV designs gas cleaning systems engineered to cost-effectively remove H2S and mercaptan-based compounds from landfill gas, digester biogas, and other waste streams. MV systems enable air emissions compliance, eliminate odor, protect people and downstream machinery, minimize maintenance costs, and help prepare gas streams for renewable energy. For more information visit: www.mvseer.com.

About Strategic Environmental & Energy Resources, Inc.

Strategic Environmental & Energy Resources, Inc. (SEER) (OTCQB: SENR), identifies, secures, and commercializes patented and proprietary environmental clean technologies in several multibillion dollar sectors (including oil & gas, renewable fuels, and all types of waste management, both solid and gaseous) for the purpose of either destroying/minimizing hazardous waste streams more safely and at lower cost than any competitive alternative, and/or processing the waste for use as a renewable fuel for the benefit of the customers and the environment. SEER has three wholly-owned operating subsidiaries: REGS, LLC; MV Technologies, LLC and SEER Environmental Materials, LLC; and three majority-owned subsidiaries: Paragon Waste Solutions, LLC; PelleChar, LLC and ReaCH4biogas, LLC. For more information about the Company visit: www.seer-corp.com.

Forward Looking Statements

This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates," and other terms with similar meaning. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. Statements in this press release regarding future performance or fiscal projections, the cost effectiveness, impact and ability of the Company's products to handle the future needs of customers are forward-looking statements. The information contained in such statements is beyond the ability of the Company to control, and in many cases the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.

SOURCE: Strategic Environmental & Energy Resources, Inc.

ReleaseID: 577500

VANCOUVER, CANADA / ACCESSWIRE / February 24, 2020 / Auryn Resources Inc. (TSX:AUG )(NYSE American:AUG) ("Auryn" or the "Company") is pleased to announce that it will be hosting an event at the Fairmont Royal York in Toronto on Monday, March 2nd at 4:00pm. The agenda will include a presentation from the Company's executive chairman, Ivan Bebek, and chief geologist, Michael Henrichsen, with a focus on Auryn's evolving Curibaya project in Peru and upcoming catalysts for 2020. This will be followed by a reception attended by other executives and geologists from the Company.

Event Details:

Auryn Presentation & Reception
Monday, March 2nd at 4:00pm EST
Fairmont Royal York – Tudor 7&8
100 Front Street West, Toronto

If you would like to attend this event, please RSVP here.

Auryn will be attending the PDAC conference, so if you are unable to attend this event, please come by booth IE2421A for an update.

On Behalf of the Board,

Ivan Bebek
Executive Chairman and Director

For further information on Auryn Resources, please contact Natasha Frakes, Manager of Corporate Communications at (778) 729-0600 info@aurynresources.com

About Auryn

Auryn Resources is a technology-driven junior exploration company focused on finding and advancing globally significant precious and base metal deposits. The company has a portfolio approach to asset acquisition and has seven projects, including two flagships: the Committee Bay high-grade gold project in Nunavut and the Sombrero copper-gold project in southern Peru. Auryn's technical and management teams have an impressive track record of successfully monetizing assets for all stakeholders and local communities in which it operates. Auryn conducts itself to the highest standards of corporate governance and sustainability.

Forward Looking Information and Additional Cautionary Language

This release includes certain statements that may be deemed "forward-looking statements". Forward-looking information is information that includes a proposed financing and completion if a proposed loan amendment as well as information relating to or associated with the acquisition and title to mineral concessions. In addition to the stated conditions to complete the transactions forward looking statements involve other known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements of the Company to be materially different (either positively or negatively) from any future results, performance or achievements expressed or implied by such forward-looking statements. Readers should refer to the risks discussed in the Company's Annual Information Form and MD&A for the year ended December 31, 2018 and subsequent continuous disclosure filings with the Canadian Securities Administrators available at www.sedar.com and the Company's registration statement on Form 40-F filed with the United States Securities and Exchange Commission and available at www.sec.gov.

The Toronto Stock Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Auryn Resources Inc.

ReleaseID: 577504

Bioactive Adrenomedullin is a biomarker for endothelial dysfunction and allows the prediction of septic shock as elevated blood levels of bio-ADM(R) predict blood pressure break down and blood vessel leakage resulting in edema

AdrenOSS-2 Phase II trial shows that modulating the Adrenomedullin plasma level with the therapeutic antibody Adrecizumab demonstrates an improvement of survival in patients with septic shock

Increased bio-ADM(R) levels were used as inclusion criteria in the AdrenOSS-2 Phase II trial to identify patients with endothelial dysfunction

sphingotec to launch IB10 sphingotest(R) bio-ADM(R) a rapid immunoassay for bioactive Adrenomedullin on its Nexus IB10 point-of-care platform mid 2020

HENNINGSDORF/BERLIN, GERMANY / ACCESSWIRE / February 24, 2020 / Diagnostics company SphingoTec GmbH ("sphingotec", Hennigsdorf, Germany) today announced that data from the AdrenOSS-2 study indicate a modulating role of bioactive Adrenomedullin in septic shock. Topline results of the AdrenOSS-2 Phase II trial released on February 21, 2020 by its sponsor Adrenomed AG (Adrenomed) showed an increase in survival for patients with septic shock when treated with Adrecizumab. Adrecizumab targets bioactive Adrenomedullin and modulates endothelial function. Septic shock is the most severe form of sepsis, a medical emergency with high mortality. In the trial, blood levels of bioactive Adrenomedullin were measured with sphingotec's quantitative bio-ADM(R) immunoassay as inclusion criteria.

Bioactive Adrenomedullin has been previously validated in over 22,000 patients as an endothelial function biomarker whose detection in the blood provides dynamic information on the patients' progression in sepsis. High or rising blood levels of bioactive Adrenomedullin indicate a disbalance in the endothelial function leading to edema and shock while decreasing levels have been linked to improved patient outcomes. Based on this evidence, bioactive Adrenomedullin is not only a valid biomarker for endothelial function but was also qualified as a biotarget and led to the subsequent development of Adrecizumab, a therapeutic antibody to treat septic shock.

In the AdrenOSS-2 Phase II trial, which was designed to evaluate the safety, tolerability, and efficacy of Adrecizumab, increased bio-ADM(R) levels were used as an inclusion criterion to select those patients with septic shock, which have an endothelial dysfunction. The trial enrolled a total of 301 patients with septic shock and was carried out in multiple clinical trial centers in Belgium, France, Germany, and The Netherlands.

In this proof-of-concept trial, patients received Adrecizumab or placebo on top of standard of care treatment. The study achieved its primary endpoint: Adrecizumab demonstrated a favorable safety profile and was well tolerated. In addition, a lower all-cause mortality for Adrecizumab-treated patients was observed when compared to placebo.

AdrenOSS-2' principal investigator Pierre-François Laterre commented: "Using bioactive Adrenomedullin blood levels as inclusion criteria allowed us to select the patients who have endothelial dysfunction. Measuring bioactive Adrenomedullin in a routine situation, furthermore allowed us to better understand the utility of this biomarker as a diagnostic tool as we saw that bioactive Adrenomedullin gave information on top of clinical standard parameters to assess patients' severity. We will now go ahead to further investigate use-cases of bioactive Adrenomedullin as a biomarker in the clinical routine."

Dr. Andreas Bergmann, founder and CEO of sphingotec commented: "Following our approach of diving deep into the biology of the disease, we have developed biomarkers that support clinicians in identifying the root causes of progression in sepsis. While the current trial indicates that using bioactive Adrenomedullin as a biomarker can help identifying those patients who could benefit in the future from Adrecizumab, the utility of this biomarker expands far beyond this and supports already today the early clinical decision making and monitoring of treatment success in sepsis."

To support the critical care community in the timely assessment of endothelial function in sepsis and other acute and critical care conditions, sphingotec will launch IB10 sphingotest(R) bio-ADM(R), a rapid test for bioactive Adrenomedullin that will be deployed on the company's proprietary point-of-care platform, the Nexus IB10 immunoassay analyzer.

###

About sphingotec

SphingoTec GmbH ("sphingotec"; Hennigsdorf near Berlin, Germany) develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, prediction and monitoring of acute medical conditions, such as sepsis, acute heart failure, circulatory shock, and acute kidney injury in order to support patient management and provide guidance for treatment strategies. sphingotec's proprietary biomarker portfolio includes Bioactive Adrenomedullin (bio-ADM(R)), a unique biomarker for real-time assessment of endothelial function in conditions like sepsis or congestive heart failure, Proenkephalin (penKid(R)), a unique biomarker for real-time assessment of kidney function, and Dipeptidyl Peptidase 3 (DPP3), a unique biomarker for cardio-renal pathway disruptions leading to acute organ dysfunction. In addition, sphingotec develops a portfolio of novel biomarkers, which predict the risks of developing obesity, breast cancer and cardiovascular diseases. IVD tests for sphingotec's proprietary biomarkers are made available as sphingotest(R) microtiterplate tests as well as point-of-care tests on the Nexus IB10 immunoassay platform by sphingotec's subsidiary Nexus Dx Inc. (San Diego, CA, USA) alongside a broad menu of IB10 tests for established biomarkers for acute and critical care.

About Nexus Dx Inc. and the IB10 Platform

Nexus Dx Inc., a wholly-owned subsidiary of sphingotec, headquartered in San Diego, CA, USA, is a global provider of a near patient testing system and advanced diagnostic solution. The company is improving patient care by providing the medical community with rapid and reliable information at the point of care (POC), delivering patient information when and where it is needed most. The company has invested over $160m to develop and market the IB10 analyzer system which, without the need for sample preparation, automatically separates plasma from whole blood with subsequent reliable and quantitative detection of biomarkers in the plasma by means of antibodies. With a hands-on-time of less than 3 minutes the easy-to-use system provides in only 20 minutes test results for biomarkers that are crucial in the management of critical care patients. The portfolio of IB10 assays includes tests for established critical care parameters such as Procalcitonin, Troponin I, CK-MB, Myoglobin, NT-proBNP, and D-Dimer as well as tests for sphingotec's proprietary biomarkers such as DPP3, an assay for Dipeptidyl Peptidase 3, a unique and proprietary biomarker for cardio-renal pathway disruptions leading to acute organ dysfunction, and Proenkephalin (penKid(R)), a unique and proprietary biomarker for real-time assessment of kidney function. An IB10 assay for bioactive Adrenomedullin (bio-ADM(R)), a unique and proprietary biomarker for endothelial function is expected to be launched later in 2020.

About bio-ADM(R)

sphingotest(R) bio-ADM(R) measures blood levels of bioactive adrenomedullin (bio-ADM(R)), a hormone maintaining endothelial function. The endothelium contributes to blood pressure and separates blood from the surrounding tissue. Elevated blood levels of bio-ADM(R) predict blood pressure break down and leaky vessels resulting in oedema. Imbalanced endothelial function is the major cause of shock ultimately resulting in organ dysfunction and death. Early identification of an imbalance in endothelial function allows guidance of vasopressor and diuretic therapy in critically ill patients to improve outcomes.

About Adrecizumab

Adrenomed's first-in-class drug candidate Adrecizumab targets adrenomedullin (ADM) to rescue endothelial barrier function (= vascular integrity). Binding of the monoclonal antibody Adrecizumab to ADM in the blood traps and stabilizes the peptide-hormone resulting in increased ADM concentrations within the blood vessels. The complex of ADM and Adrecizumab in the blood is still active. This way, Adrecizumab treatment boosts Adrenomedullin's protective effects on the endothelial barrier. www.adrenomed.com

CONTACT

SphingoTec GmbH
Ruxandra Lenz
Neuendorfstr. 15 A
16761 Hennigsdorf
Germany
Tel. +49-3302-20565-0
press@sphingotec.de
www.sphingotec.com

SOURCE: SphingoTec GmbH

ReleaseID: 577545